Levetiracetam induced psoriasiform drug eruption: a rare case report

Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Gencler, Onur Serdar, Gencler, Bilgen, Altunel, Cemile Tugba, Arslan, Nur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669462/
https://www.ncbi.nlm.nih.gov/pubmed/26702269
http://dx.doi.org/10.1016/j.jsps.2015.02.010
_version_ 1782404107630280704
author Gencler, Onur Serdar
Gencler, Bilgen
Altunel, Cemile Tugba
Arslan, Nur
author_facet Gencler, Onur Serdar
Gencler, Bilgen
Altunel, Cemile Tugba
Arslan, Nur
author_sort Gencler, Onur Serdar
collection PubMed
description Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV.
format Online
Article
Text
id pubmed-4669462
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46694622015-12-23 Levetiracetam induced psoriasiform drug eruption: a rare case report Gencler, Onur Serdar Gencler, Bilgen Altunel, Cemile Tugba Arslan, Nur Saudi Pharm J Case Report Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV. Elsevier 2015-11 2015-02-27 /pmc/articles/PMC4669462/ /pubmed/26702269 http://dx.doi.org/10.1016/j.jsps.2015.02.010 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Gencler, Onur Serdar
Gencler, Bilgen
Altunel, Cemile Tugba
Arslan, Nur
Levetiracetam induced psoriasiform drug eruption: a rare case report
title Levetiracetam induced psoriasiform drug eruption: a rare case report
title_full Levetiracetam induced psoriasiform drug eruption: a rare case report
title_fullStr Levetiracetam induced psoriasiform drug eruption: a rare case report
title_full_unstemmed Levetiracetam induced psoriasiform drug eruption: a rare case report
title_short Levetiracetam induced psoriasiform drug eruption: a rare case report
title_sort levetiracetam induced psoriasiform drug eruption: a rare case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669462/
https://www.ncbi.nlm.nih.gov/pubmed/26702269
http://dx.doi.org/10.1016/j.jsps.2015.02.010
work_keys_str_mv AT gencleronurserdar levetiracetaminducedpsoriasiformdrugeruptionararecasereport
AT genclerbilgen levetiracetaminducedpsoriasiformdrugeruptionararecasereport
AT altunelcemiletugba levetiracetaminducedpsoriasiformdrugeruptionararecasereport
AT arslannur levetiracetaminducedpsoriasiformdrugeruptionararecasereport

Ejemplares similares